Shareholder Votes

CTO Realty Growth, Inc. shareholders approved Approval of CTO Realty Growth, Inc. Sixth Amended and Restated 2010 Equity Incentive Plan at the 2026-06-17 meeting.

“Proposal 4 – Approval of the CTO Realty Growth, Inc. Sixth Amended and Restated 2010 Equity Incentive Plan: FOR AGAINST ABSTAIN BROKER NON-VOTES 18,200,389 848,986 111,850 6,648,270”

CTO Realty Growth, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-17 meeting.

“Proposal 3 – The Say-on-Pay Vote: FOR AGAINST ABSTAIN BROKER NON-VOTES 18,569,289 427,622 164,314 6,648,270”

CTO Realty Growth, Inc. shareholders approved Ratification of the appointment of Grant Thornton LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-17 meeting.

“Proposal 2 – Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year 2026: FOR AGAINST ABSTAIN 25,089,398 516,220 203,876”

CTO Realty Growth, Inc. shareholders approved Election of six directors to serve until 2027 Annual Meeting at the 2026-06-17 meeting.

“Proposal 1 – Election of Directors: DIRECTOR FOR AGAINST ABSTAIN BROKER NON-VOTES John P. Albright ‌ 19,004,020 98,000 59,204 6,648,270 George R. Brokaw ‌ 17,368,313 1,701,102 91,809 6,648,270 Christopher J. Drew ‌ 18,389,610 678,008 93,606 6,648,270 Laura M. Franklin ‌ 18,943,996 129,457 87,771 6,648,270 R. Blakeslee Gable ‌ 17,404,375 1,663,923 92,926 6,648,270 Christopher W. Haga ‌ 18,415,742 653,965 91,517 6,648,270”

Xometry, Inc. shareholders approved Ratification of the selection of Deloitte and Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“Proposal 3. Ratification of the selection of Deloitte and Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 76,747,556 43,661 15,036”

Xometry, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-06-16 meeting.

“Proposal 2. Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers. For Against Abstain Broker Non-Votes 70,965,612 1,155,515 36,882 4,648,244”

Xometry, Inc. shareholders approved Election of three Class II directors at the 2026-06-16 meeting.

“Proposal 1. Election of Directors. Name For Withheld Broker Non-Votes Roy Azevedo 71,923,642 234,367 4,648,244 Fabio Rosati 64,954,369 7,203,640 4,648,244 Katharine Weymouth 62,574,906 9,583,103 4,648,244”

IRONWOOD PHARMACEUTICALS INC shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-06-16 meeting.

“4. The stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for 2026, based on the following votes: For Against Abstain Broker Non-Votes 121,957,895 2,783,154 343,639 -”

IRONWOOD PHARMACEUTICALS INC shareholders approved Approval of Plan Amendment to increase authorized shares under the Amended and Restated 2019 Equity Incentive Plan at the 2026-06-16 meeting.

“3. The stockholders approved the Plan Amendment, based on the following votes: For Against Abstain Broker Non-Votes 104,066,785 5,404,112 166,807 15,446,984”

IRONWOOD PHARMACEUTICALS INC shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-16 meeting.

“2. The stockholders approved, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers, as disclosed in the Proxy Statement for the Annual Meeting, based on the following votes: For Against Abstain Broker Non-Votes 104,461,936 4,958,394 217,374 15,446,984”

IRONWOOD PHARMACEUTICALS INC shareholders approved Election of eight director nominees to serve on the board of directors for a one-year term at the 2026-06-16 meeting.

“1. The stockholders elected eight director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based on the following votes: Director Nominee For Withheld Broker Non-Votes Mark Currie, Ph.D. 107,222,711 2,414,993 15,446,984 Alexander Denner, Ph.D. 104,323,731 5,313,973 15,446,984 Jon Duane 105,956,515 3,681,189 15,446,984 Marla Kessler 107,142,336 2,495,368 15,446,984 Thomas McCourt 107,152,086 2,485,618 15,446,984 Julie McHugh 104,403,033 5,234,671 15,446,984 Catherine Moukheibir 106,410,985 3,226,719 15,446,984 Jay Shepard 107,209,046 2,428,658 15,446,984”

Corsair Gaming, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-06-16 meeting.

“Proposal 2. The Company’s stockholders ratified the selection of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. FOR AGAINST ABSTAIN ‎95,615,878‎ ‎370,493‎ ‎175,932‎”

Corsair Gaming, Inc. shareholders approved Election of Class III director nominees to the Board of Directors at the 2026-06-16 meeting.

“Proposal 1. The Company’s stockholders elected the Class III director nominees below to the Company’s Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. NOMINEE FOR WITHHELD BROKER NON- VOTES Thi L. La ‎77,675,295‎ 7,323,231 ‎11,163,777‎ Randall J. Weisenburger ‎72,807,885‎ 12,190,641 ‎11,163,777‎”

AGIOS PHARMACEUTICALS, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm.

“4. The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year. The results of the stockholders’ vote with respect to such ratification were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 48,511,213 116,938 15,376 0”

AGIOS PHARMACEUTICALS, INC. shareholders approved Approval of the 2023 Plan Amendment.

“3. The Company’s stockholders approved the 2023 Plan Amendment. The results of the stockholders’ vote with respect to the approval of the 2023 Plan Amendment were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 43,549,751 2,527,678 11,651 2,554,446”

AGIOS PHARMACEUTICALS, INC. shareholders approved Non-binding advisory vote on compensation paid to named executive officers.

“2. The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results of the stockholders’ non-binding, advisory vote with respect to compensation paid to the Company’s named executive officers were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 43,396,045 1,086,059 1,606,976 2,554,446”

AGIOS PHARMACEUTICALS, INC. shareholders approved Election of Class I Directors.

“1. The Company’s stockholders elected Rahul Ballal, Ph.D., Brian Goff and Cynthia Smith as Class I directors, each to serve for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified. The results of the stockholders’ vote with respect to the election of such Class I directors were as follows: Votes For Votes Withheld Broker Non-Votes Rahul Ballal, Ph.D. 40,145,081 5,943,999 2,554,446 Brian Goff 45,757,238 331,843 2,554,446 Cynthia Smith 31,496,376 14,592,704 2,554,446”

Block, Inc. shareholders rejected Stockholder proposal to establish a board-level technology committee at the 2026-06-16 meeting.

“4. Vote on Stockholder Proposal to Establish Board-Level Technology Committee Votes For Votes Against Votes Abstained Broker Non-Votes 39,387,499 954,273,725 2,828,680 55,865,373 The stockholders did not approve the stockholder proposal to establish a board-level technology committee.”

Block, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“3. Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstained 1,050,711,108 1,205,435 438,734 The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.”

Block, Inc. shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2026-06-16 meeting.

“2. Advisory Vote on Compensation of Named Executive Officers Votes For Votes Against Votes Abstained Broker Non-Votes 974,750,909 21,495,833 243,162 55,865,373 The stockholders advised that they were in favor of the compensation of the Company’s named executive officers.”

Block, Inc. shareholders approved Election of four Class II directors at the 2026-06-16 meeting.

“1. Election of Directors Nominee Votes For Votes Withheld Broker Non-Votes Roelof Botha 869,045,360 127,444,544 55,865,373 Amy Brooks 826,229,959 170,259,945 55,865,373 Shawn Carter 920,349,217 76,140,687 55,865,373 James McKelvey 935,048,041 61,441,863 55,865,373 Each director-nominee was duly elected as a Class II director to serve until the Company’s 2029 annual meeting of stockholders and until his or her successor is duly elected and qualified.”

Guardant Health, Inc. shareholders approved Advisory vote on the frequency of future stockholder advisory votes regarding the compensation of the Company’s named executive officers at the 2026-06-17 meeting.

“Proposal 4 in the Proxy Statement, a proposal to determine, on an advisory (non-binding) basis, the frequency of future stockholder advisory votes regarding the compensation of the Company’s named executive officers, was determined as follows: Votes Cast for One Year Votes Cast For Two Years Votes Cast for Three Years Abstentions Broker Non-Votes 107,997,996 14,303 265,413 165,727 7,714,711”

Guardant Health, Inc. shareholders rejected Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-17 meeting.

“Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, was not approved by the following vote: Votes For Votes Against Abstentions Broker Non-Votes 98,236,639 9,905,190 301,610 7,714,711”

Guardant Health, Inc. shareholders approved Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote: Votes For Votes Against Abstentions 115,899,030 15,250 243,870”

Guardant Health, Inc. shareholders approved Election of the nominees for director at the 2026-06-17 meeting.

“All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the “Proxy Statement”), were elected to serve on the Company’s board of directors by the following vote: Name of Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 70,526,891 37,916,548 7,714,711 Manuel Hidalgo Medina 81,925,123 26,518,316 7,714,711”

PDF SOLUTIONS INC shareholders approved Approval, by non-binding advisory vote, of the 2025 compensation awarded to Named Executive Officers at the 2026-06-16 meeting.

“Proposal No. 5 Approval, by non-binding advisory vote, of the 2025 compensation awarded to Named Executive Officers: FOR AGAINST ABSTAIN BROKER NON-VOTES 30,987,384 102,523 50,184 3,985,997”

PDF SOLUTIONS INC shareholders approved Approval of the Company's Third Amended and Restated 2021 Employee Stock Purchase Plan at the 2026-06-16 meeting.

“Proposal No. 4 Approval of the Company's Third Amended and Restated 2021 Employee Stock Purchase Plan FOR AGAINST ABSTAIN BROKER NON-VOTES 31,015,479 21,054 103,558 3,985,997”

PDF SOLUTIONS INC shareholders approved Approval of the Company's Eleventh Amended and Restated 2011 Stock Incentive Plan at the 2026-06-16 meeting.

“Proposal No. 3 Approval of the Company ’ s Eleventh Amended and Restated 2011 Stock Incentive Plan: FOR AGAINST ABSTAIN BROKER NON-VOTES 26,149,277 4,875,477 115,337 3,985,997”

PDF SOLUTIONS INC shareholders approved Ratification of the appointment of BPM LLP as the Independent Registered Public Accounting Firm for the Company for the year ending December 31, 2026 at the 2026-06-16 meeting.

“Proposal No. 2 Ratification of the appointment of BPM LLP as the Independent Registered Public Accounting Firm for the Company for the year ending December 31, 2026: FOR AGAINST ABSTAIN 34,772,285 235,698 118,105”

PDF SOLUTIONS INC shareholders approved Election of Class I Directors at the 2026-06-16 meeting.

“Proposal No. 1 Election of Class I Directors: NOMINEES FOR CLASS I DIRECTORS FOR AGAINST ABSTAIN BROKER NON-VOTES Joseph R. Bronson 29,243,333 1,851,844 44,914 3,985,997 Ye Jane Li 29,883,557 1,212,545 43,989 3,985,997”

Heartflow, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“2. The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved by the following vote: For Against Abstained Broker Non-Votes 68,735,861 717,413 130,088 N/A”

Heartflow, Inc. shareholders approved Election of Class I directors at the 2026-06-16 meeting.

“1. Each of the following Class I director nominees of the Company was elected to serve on the Company’s board of directors for a three-year term expiring at the Company’s 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified by the following vote: Nominee For Withheld Broker Non-Votes Julie A. Cullivan 51,986,481 6,046,730 11,550,151 John C.M. Farquhar 52,277,825 5,755,386 11,550,151”

ServiceTitan, Inc. shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2026-06-17 meeting.

“Proposal 3: Approval, on an advisory basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. The Company's stockholders approved, on an advisory basis, holding future advisory votes on the compensation of the Company's named executive officers every 1 year. The voting results were as follows: Votes for 1 Year Votes for 2 Years Votes for 3 Years Abstentions 188,401,434 20,715 102,404 75,586”

ServiceTitan, Inc. shareholders approved Ratification of Appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending January 31, 2027 at the 2026-06-17 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 200,500,351 48,113 70,764 N/A”

ServiceTitan, Inc. shareholders approved Election of three Class II directors to serve until the 2029 Annual Meeting at the 2026-06-17 meeting.

“Proposal 1: Election of Directors The Company's stockholders elected each of the three Class II director nominees to serve until the Company's 2029 Annual Meeting of Stockholders and until each such director's successor is duly elected and qualified. The voting results were as follows: Nominee Votes For Withhold Votes Broker Non-Votes Michael Brown 187,544,992 1,055,147 12,019,089 Byron Deeter 169,083,236 19,516,903 12,019,089 Vahe Kuzoyan 188,014,505 585,634 12,019,089”

MIAMI INTERNATIONAL HOLDINGS, INC. shareholders approved Ratification of the Appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“Proposal 4: Ratification of the Appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 74,776,726 4,868 171,700”

MIAMI INTERNATIONAL HOLDINGS, INC. shareholders approved Recommended Frequency of Say-On-Pay Vote at the 2026-06-16 meeting.

“Proposal 3: Recommended Frequency of Say-On-Pay Vote 36,641,740 391,017 29,354,149 937,071 7,629,317”

MIAMI INTERNATIONAL HOLDINGS, INC. shareholders approved Approval of the Company's Executive Compensation on an Advisory Basis at the 2026-06-16 meeting.

“Proposal 2: Approval of the Company's Executive Compensation on an Advisory Basis 49,020,028 17,331,303 972,646 7,629,317”

MIAMI INTERNATIONAL HOLDINGS, INC. shareholders approved Election of fifteen directors to hold office until the 2027 annual meeting of stockholders at the 2026-06-16 meeting.

“Proposal 1: Election of Directors Thomas P. Gallagher 66,624,613 699,364 7,629,317 Talal Jassim Al-Bahar 50,951,839 16,372,138 7,629,317 Abdulwahab Ahmad Al-Nakib 66,820,461 503,516 7,629,317 John Beckelman 66,518,057 805,920 7,629,317 David Brown 66,957,596 366,381 7,629,317 Kurt M. Eckert 66,637,205 686,772 7,629,317 Kenneth W. Lozier 66,072,284 1,251,693 7,629,317 Mark I. Massad 66,517,618 806,359 7,629,317 Lisa Moore 66,943,719 380,258 7,629,317 Mark F. Raymond 63,039,360 4,284,617 7,629,317 Cynthia Schwarzkopf 65,883,454 1,440,523 7,629,317 Eric Sites 66,143,771 1,180,206 7,629,317 Jill E. Sommers 66,978,355 345,622 7,629,317 Paul V. Stahlin 66,431,317 892,660 7,629,317 J. Gray Teekell 66,120,625 1,203,352 7,629,317”

Serve Robotics Inc. /DE/ shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2: Ratification of PwC. The Company's stockholders ratified the selection of PwC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes regarding this proposal were as follows: Votes For Votes Against Votes Abstaining/Withheld 43,715,369 246,041 254,300”

Serve Robotics Inc. /DE/ shareholders approved Election of Ali Kashani and Touraj Parang as Class III directors at the 2026-06-17 meeting.

“Proposal 1: Election of Directors. The Company's stockholders elected the following directors to serve as Class III directors. The votes regarding the election of directors were as follows: Director Votes For Votes Abstaining/ Withheld Broker Non-Votes Ali Kashani 12,185,502 2,621,065 29,409,143 Touraj Parang 11,787,105 3,019,462 29,409,143”

VEEVA SYSTEMS INC shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending January 31, 2027 at the 2026-06-17 meeting.

“Proposal 2 : The appointment of KPMG LLP as Veeva’s independent registered public accounting firm for the fiscal year ending January 31, 2027 was ratified by the shareholders based on the following results of voting: FOR AGAINST ABSTAIN 143,034,910 2,725,098 65,837”

VEEVA SYSTEMS INC shareholders approved Election of directors at the 2026-06-17 meeting.

“Proposal 1 : Each of the director nominees named below were elected to serve as directors until the 2027 annual meeting of shareholders or until his or her successor is duly elected and qualified. The vote for each director nominee is set forth in the table below: NAME FOR AGAINST ABSTAIN BROKER NON-VOTES Tim Cabral 129,552,566 2,519,259 61,233 13,692,787 Mark Carges 105,521,497 26,462,379 149,182 13,692,787 Peter P. Gassner 130,518,132 1,555,040 59,886 13,692,787 Mary Lynne Hedley 113,729,590 17,633,749 769,719 13,692,787 Priscilla Hung 130,173,979 1,888,799 70,280 13,692,787 Marshall Mohr 129,220,808 2,792,856 119,394 13,692,787 Gordon Ritter 97,109,062 34,885,018 138,978 13,692,787 Paul Sekhri 124,845,842 7,056,150 231,066 13,692,787 Matthew J. Wallach 84,161,990 47,870,106 100,962 13,692,787”

OPKO HEALTH, INC. shareholders approved Ratification of appointment of Ernst & Young LLP as independent auditor at the 2026-06-18 meeting.

“4. The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes on this proposal were as follows: For Against Abstain 535,070,921 6,120,699 2,715,188 There were no broker non-votes for the proposal.”

OPKO HEALTH, INC. shareholders approved Advisory vote to approve compensation of named executive officers at the 2026-06-18 meeting.

“3. The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 446,238,170 17,487,326 413,667 79,767,645”

OPKO HEALTH, INC. shareholders approved Approval of the Company's 2026 Equity Incentive Plan at the 2026-06-18 meeting.

“2. The stockholders voted to approve the Company’s 2026 Equity Incentive Plan as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 440,096,997 23,694,041 348,125 79,767,645”

OPKO HEALTH, INC. shareholders approved Election of Directors at the 2026-06-18 meeting.

“1. All eleven nominees were elected to the Board of Directors with each director receiving votes as follows: Election of Directors For Against Abstain Broker Non-Votes Phillip Frost, M.D. 423,666,978 40,175,942 296,243 79,767,645 Jane H. Hsiao, Ph.D. 422,928,151 40,947,325 263,687 79,767,645 Elias A. Zerhouni, M.D. 420,402,573 42,561,617 1,174,973 79,767,645 Steven D. Rubin 409,356,877 54,519,219 263,067 79,767,645 Gary J. Nabel, M.D., Ph.D. 420,083,341 43,643,796 412,026 79,767,645 Prem A. Lachman, M.D. 428,600,587 35,002,548 536,028 79,767,645 Roger J. Medel, M.D. 428,125,427 35,411,814 601,922 79,767,645 John A. Paganelli 398,032,505 65,734,019 372,639 79,767,645 Richard C. Pfenniger, Jr. 424,416,857 39,352,175 370,131 79,767,645 Subbarao V. Uppaluri, Ph.D. 454,992,813 8,481,656 664,694 79,767,645 Alice Lin-Tsing Yu, M.D., Ph.D. 418,457,740 45,287,103 394,320 79,767,645”

Nautilus Biotechnology, Inc. shareholders approved Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation at the 2026-06-17 meeting.

“The vote to approve, on an advisory basis, the frequency of future Say on Pay Votes was as follows: 1-Year 2-Years 3-Years Abstentions 69,142,818 6,733 1,112,824 31,198”

Nautilus Biotechnology, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-17 meeting.

“The vote to approve, on an advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2025 (the “Say on Pay Vote”) was as follows: Votes For Votes Against Abstentions Broker Non-Votes 69,994,022 268,341 31,210 14,708,618”

Nautilus Biotechnology, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting: Votes For Votes Against Abstentions 84,937,704 27,748 36,739”